Originally designed as a treatment for type II diabetes, in 2021, the FDA approved Semaglutide to be used as a weight loss treatment
CagriSema combines two proven mechanisms (amylin + GLP-1) in a fixed-dose injection, achieving 20.4% weight loss in Phase 3, with an NDA already filed and the advantage of building on the well-characterized semaglutide platform
Our products are not intended for human consumption, medical, or therapeutic applications
This ensures that nutrients such as biotin, zinc, and vitamin B12 are properly absorbed and used by your body
For example, if a patient has trouble swallowing pills, the compounding pharmacy can create a compounded semaglutide that is administered as a liquid or a nasal spray
Gina Guzman and Dr